Role of viral vectors and virion shells in cellular gene expression

Molecular Therapy

Volumn 9, Issue 3, 2004, Pages 337-346

  Stilwell, Jackie L ^a   Samulski, Richard Jude ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DNA; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENE TRANSFER; HOST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INHIBITION KINETICS; INTERMETHOD COMPARISON; NONHUMAN; NUCLEOTIDE SEQUENCE; SAFETY; STRESS; UNINDEXED SEQUENCE; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS CAPSID; VIRUS INFECTION; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; WILD TYPE;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE;

EID: 1642525192     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.11.007     Document Type: Article

References (44)

1. DeRisi, J. L., Iyer, V. R., and Brown, P. O. (1997). Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278: 680-686.
2. Lee, C. K., Klopp, R. G., Weindruch, R., and Prolla, T. A. (1999). Gene expression profile of aging and its retardation by caloric restriction [see comments]. Science 285:1390-1393.
3. Ly, D. H., Lockhart, D. J., Lerner, R. A., and Schultz, P. G. (2000). Mitotic misregulation and human aging [see comments]. Science 287: 2486-2492.
4. Zhu, H., Cong, J. P., Mamtora, G., Gingeras, T., and Shenk, T. (1998). Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95: 14470-14475.
5. Haberberger, T. C., Kupfer, K., and Murphy, J. E. (2000). Profiling of genes which are differentially expressed in mouse liver in response to adenoviral vectors and delivered genes. Gene Ther. 7: 903-909.
6. Scherf, U., et al. (2000). A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24: 236-244.
7. Bantel-Schaal, U., and Stohr, M. (1992). Influence of adeno-associated virus on adherence and growth properties of normal cells. J. Virol. 66: 773-779.
8. Kube, D. M., Ponnazhagan, S., and Srivastava, A. (1997). Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells. J. Virol. 71: 7361-7371.
9. Stilwell, J. L., and Samulski, R. J. (2003). Adeno-associated virus vectors for therapeutic gene transfer. Biotechniques 34: 148-150, 152, 154 passim.
10. Moore, A. G., et al. (2000). The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J. Clin. Endocrinol. Metab. 85: 4781-4788.
11. Brenner, M. (1999). Gene transfer by adenovectors. Blood 94: 3965-3967.
12. Schnell, M. A., et al. (2001). Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol. Ther. 3: 708-722.
13. Zhang, Y., et al. (2001). Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol. Ther. 3: 697-707.
14. Driesse, M. J., et al. (2000). Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity. Gene Ther. 7: 1401-1409.
15. Liu, Q., et al. (2003). The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Hum. Gene Ther. 14: 627-643.
16. Zaiss, A. K., et al. (2002). Differential activation of innate immune responses by adeno-virus and adeno-associated virus vectors. J. Virol. 76: 4580-4590.
17. Bruder, J. T., and Kovesdi, I. (1997). Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J. Virol. 71: 398-404.
18. Daly, C., and Reich, N. C. (1993). Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element. Mol. Cell. Biol. 13: 3756-3764.
19. Weaver, B. K., Kumar, K. P., and Reich, N. C. (1998). Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18: 1359-1368.
20. Liu, Q., and Muruve, D. A. (2003). Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10: 935-940.
21. Takekawa, M., Posas, F., and Saito, H. (1997). A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinase, MTK1, mediates stress-induced activation of the p38 and JNK pathways. EMBO J. 16: 4973-4982.
22. Takekawa, M., and Saito, H. (1998). A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95: 521-530.
23. Sargent, C. A., Dunham, I., Trowsdale, J., and Campbell, R. D. (1989). Human major histocompatibility complex contains genes for the major heat shock protein HSP70. Proc. Natl. Acad. Sci. USA 86: 1968-1972.
24. Liu, C., Rangnekar, V. M., Adamson, E., and Mercola, D. (1998). Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther. 5: 3-28.
25. Chen, H. H., et al. (1997). Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. USA 94: 1645-1650.
26. Thomas, C. E., Ehrhardt, A., and Kay, M. A. (2003). Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4: 346-358.
27. Jooss, K., and Chirmule, N. (2003). Immunity to adenovirus and adeno-associated viral vectors: Implications for gene therapy. Gene Ther. 10: 955-963.
28. Amin, R., Wilmott, R., Schwarz, Y., Trapnell, B., and Stark, J. (1995). Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vitro. Hum. Gene Ther. 6: 145-153.
29. Bootcov, M. R., et al. (1997). MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc. Natl. Acad. Sci. USA 94: 11514-11519.
30. Yang, Y., Li, Q., Ertl, H. C., and Wilson, J. M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004-2015.
31. Saudan, P., Vlach, J., and Beard, P. (2000). Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J. 19: 4351-4361.
32. Gao, G. P., Yang, Y., and Wilson, J. M. (1996). Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70: 8934-8943.
33. Dedieu, J. F., et al. (1997). Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J. Virol. 71: 4626-4637.
34. Christ, M., et al. (2000). Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products. Hum. Gene Ther. 11: 415-427.
35. Oka, K., et al. (2001). Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation 103: 1274-1281.
36. Nichols, W. W., et al. (1977). Characterization of a new human diploid cell strain, IMR-90. Science 196: 60-63.
37. Xiao, X., Li, J., and Samulski, R. J. (1998). Production of high titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72: 2224-2232.
38. Summerford, C., and Samulski, R. J. (1999). Viral receptors and vector purification: New approaches for generating clinical-grade reagents. Nat. Med. 5: 587-588.
39. Zolotukhin, S., et al. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6: 973-985.
40. Samulski, R. J., Chang, L. -S., and Shenk, T. (1987). A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61: 3096-3101.
41. Jones, N. C., and Shenk, T. (1979). An adenovirus type 5 early region gene function regulates expression of other early viral genes. Proc. Natl. Acad. Sci. USA 76: 3665-3669.
42. Stilwell, J. L., McCarty, D. M., Negishi, A., Superfine, R., and Samulski, R. J. (2003). Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression. J. Virol. 77: 12881-12885.
43. Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., and Phipps, M. L. (1997). Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71: 1842-1849.
44. Haberman, R. P., Kroner-Lux, G., and R. J. S. (1999). Production of adeno-associated virus vectors. In Current Protocols in Human Genetics (N. Dracopoli, et al., Eds.), pp. 12.9.1 -12.9.16. New York: Wiley.